The coroner is set to decide on whether there were "missed opportunities" in the care of a 22-year-old from Bolton ...

Biogen (NASDAQ:BIIB) executives highlighted progress across several pipeline programs during a discussion that focused on the company’s tau antisense oligonucleotide (ASO) program in Alzheimer’s ...

The number in the Ambitious Australia report that should embarrass every Canberra policymaker is $2 - a quarter of CSF investment in the UK.

C2N Diagnostics, LLC ("C2N"), a specialty diagnostics company with a vision to bring Clarity Through Innovation (R), highlighted the first use of its eMTBR-tau243 plasma assay in a Phase 3 dataset ...

Researchers found that sargramostim decreased UCH-L1 and total tau levels in mild-to-moderate Alzheimer’s patients. MMSE cognitive scores improved, and mouse models confirmed reduced neuronal ...

Management prioritizes 5%–10% weight loss and acetazolamide titration guided by Frisén grading, OCT, and visual fields; refractory or vision-threatening disease may need ONSF or CSF shunting.

Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating Fast Track designated ...

The 'two-strikes-and-out' doping rule on teams can seem blunt and unfair, but cycling’s history means the sport still can’t ...

An analysis of 76 million people found that those who had been ill with Covid were at greater risk of developing one cancer ...

Advanced proteomics and AI reveal blood protein changes, offering insights into early Alzheimer's detection and differentiation from mild cognitive impairment.

Those who have contracted Covid could be at an increased risk of lung cancer, scientists have found. The research indicates ...

People hospitalised with severe COVID-19 had a 24 per cent higher risk ...